Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

Published:2011-08-17 Issue:96 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Dudley Joel T.¹²³,Sirota Marina¹²³,Shenoy Mohan⁴,Pai Reetesh K.⁵,Roedder Silke¹³,Chiang Annie P.¹²³,Morgan Alex A.¹²³,Sarwal Minnie M.¹³,Pasricha Pankaj Jay⁴,Butte Atul J.¹³

Affiliation:

1. Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, 251 Campus Drive, Stanford, CA 94305–5415, USA.

2. Training Program in Biomedical Informatics, Stanford University School of Medicine, Stanford, CA 94305–5479, USA.

3. Lucile Packard Children’s Hospital, 725 Welch Road, Palo Alto, CA 94304, USA.

4. Division of Gastroenterology, Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305–5187, USA.

5. Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305–5324, USA.

Abstract

Computationally predicted repositioning of an anticonvulsant for inflammatory bowel disease is confirmed experimentally.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference22 articles.

1. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

2. Inflammatory bowel disease: clinical aspects and established and evolving therapies

3. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

4. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

5. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Cited by 513 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing Treatment Options for IBD through Drug Repurposing;Current Pharmaceutical Design;2024-09

2. Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology;Human Gene;2024-09

3. RNA Sequencing in Disease Diagnosis;Annual Review of Genomics and Human Genetics;2024-08-27

4. Machine Learning and Artificial Intelligence in Drug Repurposing—Challenges and Perspectives;Drug Repurposing;2024-07-03

5. Integrated edge information and pathway topology for drug-disease associations;iScience;2024-07